In addition, Sanders and coworkers demonstrated amelioration of pulmonary fibrosis in response to global HDAC inhibition by SAHA (vorinostat) in bleomycin-treated mice in vivo [33]. This evidence concerns the gene HDAC9 and pulmonary fibrosis.